Investor News & Updates

two people talking in front of bayer logo

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

1 - 10of 409 News
1 - 10of 409 News
February 19, 2025
Not intended for UK Media
AskBio Receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’s disease investigational gene therapy
READ MORE
February 14, 2025
Not intended for U.S. and UK Media
Bayer files for approval of finerenone in heart failure in Japan
READ MORE
February 11, 2025
Not intended for U.S. and UK Media
Heart drug Beyonttra™ (acoramidis) approved in EU for treatment of transthyretin amyloidosis in adults with cardiomyopathy
READ MORE
February 10, 2025
Not intended for U.S. and UK Media
Bayer files for approval of extended 6-month treatment interval for Eylea™ 8 mg in the EU
READ MORE
February 08, 2025
Not intended for U.S. and UK Media
Long-term efficacy and safety of Eylea™ 8 mg with extended dosing intervals in wet age-related macular degeneration confirmed at three years
READ MORE
February 03, 2025
Not intended for U.S. and UK Media
Bayer files for approval of finerenone in heart failure in the EU
READ MORE
January 14, 2025
Not intended for U.S. and UK Media
Bayer’s Pharma Growth Strategy Progressing Well as Pipeline Advances
READ MORE
January 13, 2025
Not intended for UK Media
BlueRock Therapeutics advances investigational cell therapy bemdaneprocel for treating Parkinson’s disease to registrational Phase III clinical trial
READ MORE
January 10, 2025
Not intended for U.S. and UK Media
Bayer submits application to U.S. FDA and to China’s CDE for new indication of finerenone for patients with common form of heart failure with high unmet medical need
READ MORE
January 10, 2025
Not intended for UK Media
Bayer’s investigational MRI contrast agent gadoquatrane meets primary and main secondary endpoints in pivotal Phase III studies
READ MORE
1 - 10of 409 News
1 - 10of 409 News
Inform Yourself on Special Topics
Control Weeds Not Farming

Control Weeds, Not Farming

LEARN MORE
Farmers discussing their weed management

Everything You Need to Know About Glyphosate

LEARN MORE
some-bayer-group-headquarters

Managing Glyphosate Litigation

learn more
woman harvesting carrots

Managing and Mitigating PCB Litigation Risk

learn more